| Continuous glucose monitoring-enabled insulin-pump therapy in diabetic pregnancy. | |
| | |
MedLine Citation:
|
PMID: 20804351 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We describe the feasibility of continuous glucose monitoring (CGM)-enabled insulin-pump therapy during pregnancy in a woman with type 1 diabetes, who was treated with CGM-enabled insulin-pump therapy in her third pregnancy. During her first pregnancy, the woman was treated with multiple daily injections and baseline HbA1c was 8.9%. Due to pre-eclampsia, the child was born preterm, and had neonatal hypoglycemia. In the planning of the second pregnancy, insulin-pump therapy was initiated, resulting in an HbA1c of 6.8% in early pregnancy. Due to pre-eclampsia, the second child was born preterm, but without neonatal morbidity. Before her third pregnancy, CGM-enabled insulin-pump therapy was introduced, and HbA1c was 6.4% in early pregnancy. The patient was satisfied with this therapy, pre-eclampsia did not occur, and the child was born at term without neonatal morbidity. CGM-enabled insulin-pump therapy appears feasible in diabetic pregnancies. |
| | |
Authors:
|
Anna L Secher; Signe Schmidt; Kirsten Nørgaard; Elisabeth R Mathiesen |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Acta obstetricia et gynecologica Scandinavica Volume: 89 ISSN: 1600-0412 ISO Abbreviation: Acta Obstet Gynecol Scand Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-08-31 Completed Date: 2010-09-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370343 Medline TA: Acta Obstet Gynecol Scand Country: England |
Other Details:
|
Languages: eng Pagination: 1233-7 Citation Subset: IM |
Affiliation:
|
Center for Pregnant Women with Diabetes, Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark. anna.lilja.secher@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Blood Glucose / analysis Diabetes Mellitus, Type 1 / drug therapy* Feasibility Studies Female Hemoglobin A, Glycosylated / analysis Humans Hypoglycemic Agents / therapeutic use* Infant, Newborn Insulin / therapeutic use* Insulin Infusion Systems* Monitoring, Ambulatory Pregnancy Pregnancy in Diabetics / drug therapy* Term Birth |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Hemoglobin A, Glycosylated; 0/Hypoglycemic Agents; 0/hemoglobin A1c protein, human; 11061-68-0/Insulin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Morbidity associated with failed vaginal birth after cesarean section.
Next Document: Gynaecological oncology.